BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21206375)

  • 1. Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy.
    Bryson EO; Aloysi AS; Perez AM; Popeo D; Kellner CH
    J ECT; 2011 Mar; 27(1):e42-3. PubMed ID: 21206375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine.
    Turkkal DC; Gokmen N; Yildiz A; Iyilikci L; Gokel E; Sagduyu K; Gunerli A
    J Clin Anesth; 2008 Dec; 20(8):589-93. PubMed ID: 19100931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of succinylcholine for electroconvulsive therapy after organophosphate poisoning: a case study.
    Dillard M; Webb J
    AANA J; 1999 Dec; 67(6):513-7. PubMed ID: 10876443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.
    Mollerup HM; Gätke MR
    Acta Anaesthesiol Scand; 2011 Jan; 55(1):82-6. PubMed ID: 21029050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinylcholine drug interactions during electroconvulsive therapy.
    Marco LA; Randels PM
    Biol Psychiatry; 1979 Apr; 14(2):433-45. PubMed ID: 476229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy.
    Cheam EW; Critchley LA; Chui PT; Yap JC; Ha VW
    Can J Anaesth; 1999 Jan; 46(1):49-51. PubMed ID: 10078403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy complicated by life-threatening hyperkalemia in a catatonic patient.
    Hudcova J; Schumann R
    Gen Hosp Psychiatry; 2006; 28(5):440-2. PubMed ID: 16950383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intrasubject comparison of two doses of succinylcholine in modified electroconvulsive therapy.
    Murali N; Saravanan ES; Ramesh VJ; Gangadhar BN; Jananakiramiah N; Kumar SS; Christopher R; Subbakrishna DK
    Anesth Analg; 1999 Nov; 89(5):1301-4. PubMed ID: 10553856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe bradycardia after anesthesia before electroconvulsive therapy.
    Birkenhäger TK; Pluijms EM; Groenland TH; van den Broek WW
    J ECT; 2010 Mar; 26(1):53-4. PubMed ID: 19710620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of myalgia in electroconvulsive therapy.
    Rasmussen KG; Petersen KN; Sticka JL; Wieme LJ; Zosel JH; Marienau ME; Ryan DA; Schroeder DR; Stevens SR; Hooten WM; Spackman TN
    J ECT; 2008 Mar; 24(1):84-7. PubMed ID: 18379340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cardiac output and onset of succinylcholine chloride action in electroconvulsive therapy patients.
    Matsumoto N; Tomioka A; Sato T; Kawasaki M; Kadoi Y; Saito S
    J ECT; 2009 Dec; 25(4):246-9. PubMed ID: 19252443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudocholinesterase deficiency and electroconvulsive therapy.
    Williams J; Rosenquist P; Arias L; McCall WV
    J ECT; 2007 Sep; 23(3):198-200. PubMed ID: 17805000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.
    Waghmare A; Kumar CN; Thirthalli J
    Gen Hosp Psychiatry; 2010; 32(4):447.e1-2. PubMed ID: 20633755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anesthesia for electroconvulsive therapy: clinical experience].
    González AG; Cortínez LI; De la Cuadra JC; Carrasco E; Rioseco A; Léniz P
    Rev Esp Anestesiol Reanim; 2007; 54(7):414-20. PubMed ID: 17953335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electroconvulsive Therapy Considerations for Transgendered Patients.
    Tran BK; O'Donnell SE; Balla A; Adams DC; Grondin LS; Tsai MH
    J ECT; 2017 Jun; 33(2):e14-e16. PubMed ID: 28009618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of negative-pressure pulmonary edema after electroconvulsive therapy.
    Myers CL; Gopalka A; Glick D; Goldman MB; Dinwiddie SH
    J ECT; 2007 Dec; 23(4):281-3. PubMed ID: 18090704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of remifentanil and alfentanil on seizure duration, stimulus amplitudes and recovery parameters during ECT.
    Akcaboy ZN; Akcaboy EY; Yigitbasł B; Bayam G; Dikmen B; Gogus N; Dilbaz N
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1068-71. PubMed ID: 16095445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoimmunotherapy for autochthonous acute rat leukemias.
    Zeller WJ; Reusch K; Schmähl D
    Cancer Treat Rep; 1982 Feb; 66(2):391-4. PubMed ID: 7055821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.